[breadcrumb_custom]

Does Omega Therapeutics Inc (NASDAQ:OMGA) Look Expensive At $3.86? Here’s How To Know.

In last trading session, Omega Therapeutics Inc (NASDAQ:OMGA) saw 0.65 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price level of $3.86 trading at $0.26 or 7.22% at ring of the bell on the day assigns it a market valuation of $212.84M. That closing price of OMGA’s stock is at a discount of -161.4% from its 52-week high price of $10.09 and is indicating a premium of 66.32% from its 52-week low price of $1.30. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.68 million shares which gives us an average trading volume of 2.08 million if we extend that period to 3-months.

Omega Therapeutics Inc (NASDAQ:OMGA) trade information

Upright in the green during last session for gaining 7.22%, in the last five days OMGA remained trading in the green while hitting it’s week-highest on Friday, 02/09/24 when the stock touched $3.86 price level, adding 1.53% to its value on the day. Omega Therapeutics Inc’s shares saw a change of 28.24% in year-to-date performance and have moved 10.92% in past 5-day. Omega Therapeutics Inc (NASDAQ:OMGA) showed a performance of -23.41% in past 30-days. Number of shares sold short was 3.62 million shares which calculate 0.72 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Omega Therapeutics Inc (OMGA) estimates and forecasts

Statistics highlight that Omega Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 2.39% of value to its shares in past 6 months, showing an annual growth rate of 9.81% while that of industry is 15.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 29.70% in the current quarter and calculating 16.00% increase in the next quarter. This year revenue growth is estimated to rise 23.50% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $570k for the same. And 4 analysts are in estimates of company making revenue of $460k in the next quarter that will end on Mar 2024. Company posted $735k and $260k of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -22.40% while estimating it to be 76.90% for the next quarter.

OMGA Dividends

Omega Therapeutics Inc is more likely to be releasing its next quarterly report in March and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

On Key

Related Posts